[Effect of various drugs on metabolism of skeletal muscles. 3. Effect of cholinergic, cholinesterase inhibitor and neuromuscular blocking agents on oxygen consumption of the skeletal musscles].
D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D005449:Fluorenes / Q000494:pharmacology; D066298:In Vitro Techniques; D009132:Muscles / Q000187:drug effects* / Q000378:metabolism; D009388:Neostigmine / Q000494:pharmacology; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects*; D010277:Parasympathomimetics / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011898:Ranidae; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D005449:Fluorenes; D009467:Neuromuscular Depolarizing Agents; D010277:Parasympathomimetics; D000644:Quaternary Ammonium Compounds; D009388:Neostigmine; D002110:Caffeine; D002217:Carbachol; D010830:Physostigmine; D011433:Propranolol; D013390:Succinylcholine; D011188:Potassium; D014403:Tubocurarine; D010646:Phentolamine